FDA Inspection 1323324 — The Mount Sinai Hospital

The Mount Sinai Hospital — FEI 2470025

The FDA completed an inspection of The Mount Sinai Hospital on June 8, 2026 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 8, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
New York, NY (United States)